This newest twist from the Lykos Therapeutics saga threatens A significant overhaul of the organization’s method and path, with Musk ally and billionaire investor Antonio Gracias appearing to wish to take the business back towards its nonprofit drug advancement roots and a far more Doblinite philosophy., James writes about why so Lots of people �